IL32462A - N-substituted lysergamide derivatives - Google Patents
N-substituted lysergamide derivativesInfo
- Publication number
- IL32462A IL32462A IL32462A IL3246269A IL32462A IL 32462 A IL32462 A IL 32462A IL 32462 A IL32462 A IL 32462A IL 3246269 A IL3246269 A IL 3246269A IL 32462 A IL32462 A IL 32462A
- Authority
- IL
- Israel
- Prior art keywords
- formula
- compound
- acid
- solution
- isopropyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/02—Ergot alkaloids of the cyclic peptide type
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH951568A CH508628A (de) | 1968-06-25 | 1968-06-25 | Verfahren zur Herstellung neuer heterocyclischer Verbindungen |
Publications (2)
Publication Number | Publication Date |
---|---|
IL32462A0 IL32462A0 (en) | 1969-08-27 |
IL32462A true IL32462A (en) | 1973-07-30 |
Family
ID=4352804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL32462A IL32462A (en) | 1968-06-25 | 1969-06-23 | N-substituted lysergamide derivatives |
Country Status (17)
Country | Link |
---|---|
US (1) | US3666762A (fi) |
AT (1) | AT308288B (fi) |
BE (1) | BE734999A (fi) |
BR (1) | BR6910095D0 (fi) |
CA (1) | CA947291A (fi) |
CH (1) | CH508628A (fi) |
DE (1) | DE1931081A1 (fi) |
DK (1) | DK127644B (fi) |
ES (1) | ES368721A1 (fi) |
FI (1) | FI49517C (fi) |
FR (1) | FR2011659A1 (fi) |
GB (1) | GB1266744A (fi) |
IL (1) | IL32462A (fi) |
NL (1) | NL6908302A (fi) |
PL (1) | PL80112B1 (fi) |
SE (1) | SE355810B (fi) |
SU (1) | SU372813A3 (fi) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1298277A (en) * | 1969-04-18 | 1972-11-29 | Sandoz Ltd | Preparation of ergot peptide alkaloids |
US3846433A (en) * | 1969-05-06 | 1974-11-05 | Sandoz Ltd | Process for preparing ergot alkaloids |
US4138565A (en) * | 1975-05-31 | 1979-02-06 | Sandoz Ltd. | Stable solutions and processes for their preparation |
GB1584464A (en) * | 1977-04-19 | 1981-02-11 | Farmaceutici Italia | Ergot alkaloids |
EP2515654A4 (en) * | 2009-12-23 | 2013-04-24 | Map Pharmaceuticals Inc | NEW ERGOLINANALOGA |
MX2013015373A (es) | 2011-06-23 | 2014-02-11 | Map Pharmaceuticals Inc | Nuevos analogos de fluoroergolina. |
SG11201403434YA (en) | 2011-12-19 | 2014-09-26 | Map Pharmaceuticals Inc | Novel iso-ergoline derivatives |
SG10201506202RA (en) | 2011-12-21 | 2015-09-29 | Map Pharmaceuticals Inc | Novel neuromodulatory compounds |
US9012640B2 (en) | 2012-06-22 | 2015-04-21 | Map Pharmaceuticals, Inc. | Cabergoline derivatives |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH344731A (de) * | 1956-05-18 | 1960-02-29 | Sandoz Ag | Verfahren zur Herstellung von neuen, am Indolstickstoff alkylierten Derivaten der Lysergsäure-Reihe |
CH395119A (de) * | 1961-05-10 | 1965-07-15 | Sandoz Ag | Verfahren zur Herstellung von heterocyclischen Verbindungen |
GB1011112A (en) * | 1961-05-10 | 1965-11-24 | Sandoz Ag | Improvements in or relating to ergot alkaloids |
CH469735A (de) * | 1965-11-02 | 1969-03-15 | Sandoz Ag | Verfahren zur Herstellung heterocyclischer Verbindungen |
FR1583797A (fi) * | 1967-04-12 | 1969-12-05 |
-
1968
- 1968-06-25 CH CH951568A patent/CH508628A/de not_active IP Right Cessation
-
1969
- 1969-05-30 NL NL6908302A patent/NL6908302A/xx unknown
- 1969-06-04 SE SE07873/69A patent/SE355810B/xx unknown
- 1969-06-04 DK DK304369AA patent/DK127644B/da unknown
- 1969-06-04 FI FI691673A patent/FI49517C/fi active
- 1969-06-09 GB GB1266744D patent/GB1266744A/en not_active Expired
- 1969-06-19 DE DE19691931081 patent/DE1931081A1/de active Pending
- 1969-06-23 IL IL32462A patent/IL32462A/en unknown
- 1969-06-23 CA CA55050A patent/CA947291A/en not_active Expired
- 1969-06-23 PL PL1969134334A patent/PL80112B1/pl unknown
- 1969-06-23 BE BE734999D patent/BE734999A/xx unknown
- 1969-06-24 ES ES368721A patent/ES368721A1/es not_active Expired
- 1969-06-24 FR FR6921113A patent/FR2011659A1/fr not_active Withdrawn
- 1969-06-24 SU SU1339554A patent/SU372813A3/ru active
- 1969-06-24 BR BR210095/69A patent/BR6910095D0/pt unknown
- 1969-06-24 AT AT599569A patent/AT308288B/de active
- 1969-11-03 US US873645A patent/US3666762A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
PL80112B1 (fi) | 1975-08-30 |
AT308288B (de) | 1973-06-25 |
DE1931081A1 (de) | 1970-01-15 |
FR2011659A1 (fi) | 1970-03-06 |
SE355810B (fi) | 1973-05-07 |
IL32462A0 (en) | 1969-08-27 |
FI49517B (fi) | 1975-04-01 |
BE734999A (fi) | 1969-12-23 |
GB1266744A (fi) | 1972-03-15 |
DK127644B (da) | 1973-12-10 |
CA947291A (en) | 1974-05-14 |
BR6910095D0 (pt) | 1973-02-08 |
NL6908302A (fi) | 1969-12-30 |
CH508628A (de) | 1971-06-15 |
ES368721A1 (es) | 1971-06-16 |
FI49517C (fi) | 1975-07-10 |
US3666762A (en) | 1972-05-30 |
SU372813A3 (fi) | 1973-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0028834B1 (en) | Imidazole-5-acetic acid derivatives, their production and use | |
US3586683A (en) | 2,5(5) - di(tri)substituted - 10b-hydroxy-3,6 - dioxo-octahydro-oxazolo(3,2-a) pyrrolo(2,1-c)pyrazine derivatives of lysergic acid | |
IL32462A (en) | N-substituted lysergamide derivatives | |
US3652569A (en) | Ergonine ergoptine and the 1-methyl and 9 10-dihydro derivatives thereof | |
CS202600B2 (en) | Process for preparing new derivatives of 5,11-dihydro-6h-pyrido/2,3-b//1,4/benzodiazepin-6-one | |
CA1250582A (en) | Tetrahydrocorynantheine derivatives and process for their preparation | |
US3984556A (en) | Alkyl-substituted-tricyclic quinazolinones for lowering blood pressure | |
GB1569251A (en) | Pyridobenzodiazepines | |
US4088647A (en) | Pyrazino (1,2,3-ab)-β-carboline derivatives and salts thereof and method of preparing same | |
US3996228A (en) | Pyrimidinoaminoethyl ergoline derivatives | |
US4124712A (en) | Ergot peptide alkaloid derivatives | |
US3681355A (en) | Ergonarcarnines | |
US4432990A (en) | 5-Aminoimidazoles as immunoregulants | |
US3422110A (en) | Ergot alkaloids methylated in the 10a'-position | |
US3583991A (en) | 6-methyl-8-piperazinyl-methylergalene (ergoline) derivatives | |
US4609657A (en) | Ergot peptide alkaloid derivatives, processes for their preparation and pharmaceutical compositions containing them | |
US3415831A (en) | 2-isoquinolinyl(and carbolinyl) alkyloctahydroindolo [2,3-a]-quinolizines | |
US3772299A (en) | P'-alkoxy-ergotamines | |
US3592816A (en) | N-substituted piperazides of lysergic acid | |
US4235903A (en) | 1-Hydroxyalkanamine tetrahydrocarbazoles and cyclopent[b]indoles, compositions and method of use | |
US3410844A (en) | 2, 3, 4, 5-tetrahydro-2-oxo-1h-1, 4-benzodiazepine-3-carboxylic acid, esters and related compounds | |
US4425350A (en) | 5,6,6a,7-Tetrahydro-4H-dibenz(de,g)-isoquinoline derivatives, and their use for treating central nervous system disorders | |
US4002638A (en) | Benzazepine derivatives | |
FI76083C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara 5,6-dihydro-11-alkylenmorfantridin-6-oner. | |
US3911017A (en) | 5-Aminomethyl-5H-dibenzo{8 a,d{9 cycloheptenes |